avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PAX5
|
ENSG00000196092.8 | paired box 5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PAX5 | hg19_v2_chr9_-_37034028_37034157 | -0.15 | 5.2e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 21.5 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
3.7 | 11.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
3.4 | 13.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.4 | 7.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
2.3 | 14.0 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
2.1 | 6.4 | GO:1904301 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.7 | 5.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
1.5 | 4.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
1.5 | 8.9 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.4 | 4.3 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
1.4 | 11.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
1.4 | 4.1 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
1.3 | 5.3 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
1.3 | 9.3 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.3 | 3.9 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
1.3 | 7.7 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.3 | 5.0 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
1.2 | 12.2 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
1.2 | 3.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
1.2 | 6.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.2 | 3.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.2 | 3.6 | GO:2000452 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
1.2 | 42.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 7.8 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
1.1 | 3.3 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
1.1 | 3.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.1 | 5.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.1 | 9.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.0 | 19.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.0 | 7.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.0 | 1.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
1.0 | 3.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.0 | 2.9 | GO:0008057 | eye pigment granule organization(GO:0008057) |
1.0 | 3.9 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
1.0 | 3.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.9 | 0.9 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
0.9 | 6.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.9 | 2.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.9 | 3.6 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.9 | 3.5 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.9 | 6.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.9 | 3.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.8 | 2.5 | GO:0048627 | myoblast development(GO:0048627) |
0.8 | 5.1 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.8 | 9.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.8 | 4.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 4.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.8 | 2.4 | GO:0032903 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.8 | 2.4 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
0.8 | 2.4 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.8 | 2.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.8 | 6.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.7 | 3.7 | GO:0032796 | uropod organization(GO:0032796) |
0.7 | 2.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.7 | 2.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.7 | 0.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.7 | 2.9 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.7 | 2.9 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.7 | 5.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 2.8 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.7 | 3.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.7 | 4.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.7 | 5.4 | GO:0030578 | PML body organization(GO:0030578) |
0.7 | 4.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.7 | 1.3 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
0.7 | 3.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.6 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
0.7 | 3.3 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.7 | 2.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.7 | 2.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.6 | 1.9 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.6 | 7.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.6 | 0.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 2.5 | GO:1904647 | response to rotenone(GO:1904647) |
0.6 | 1.9 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.6 | 1.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.6 | 6.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 1.9 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.6 | 1.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.6 | 0.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.6 | 2.5 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.6 | 3.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.6 | 2.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 1.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.6 | 2.9 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.6 | 2.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 4.0 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.6 | 0.6 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.6 | 1.7 | GO:1900081 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.6 | 2.8 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.6 | 2.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 2.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 0.6 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.6 | 2.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 2.7 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.5 | 2.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.5 | 1.1 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.5 | 2.1 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.5 | 3.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 5.2 | GO:1990834 | response to odorant(GO:1990834) |
0.5 | 1.0 | GO:0072535 | tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
0.5 | 1.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.5 | 2.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.5 | 1.5 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.5 | 1.5 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.5 | 2.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.5 | 2.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.5 | 3.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 2.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.5 | 1.5 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.5 | 1.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.5 | 3.0 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.5 | 5.9 | GO:0021759 | globus pallidus development(GO:0021759) |
0.5 | 2.9 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.5 | 1.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.5 | 0.5 | GO:0018963 | phthalate metabolic process(GO:0018963) |
0.5 | 2.9 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.5 | 3.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.5 | 1.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 7.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.5 | 5.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 7.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 1.4 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.5 | 3.7 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.5 | 5.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 11.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.5 | 2.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.5 | 2.3 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.4 | 1.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.4 | 2.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 3.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 1.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.4 | 4.4 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.4 | 1.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.4 | 2.2 | GO:1903923 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) protein processing in phagocytic vesicle(GO:1900756) regulation of plasma membrane raft polarization(GO:1903906) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.4 | 7.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 0.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.4 | 7.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 1.3 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 2.5 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.4 | 1.3 | GO:0061433 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
0.4 | 4.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 2.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 0.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.4 | 1.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.4 | 0.4 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.4 | 0.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.4 | 2.0 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.4 | 3.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.4 | 6.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 2.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.4 | 1.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.4 | 8.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.4 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 1.2 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.4 | 2.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.4 | 1.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.4 | 2.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 0.8 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.4 | 1.9 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.4 | 8.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 3.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.9 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 0.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 3.0 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.4 | 2.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.4 | 2.6 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.4 | 1.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.4 | 1.5 | GO:0006788 | heme oxidation(GO:0006788) |
0.4 | 2.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.4 | 1.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.4 | 1.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.4 | 1.8 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.4 | 2.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 1.8 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.4 | 0.4 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.4 | 0.7 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.3 | 1.0 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 0.3 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.3 | 2.8 | GO:0042048 | olfactory behavior(GO:0042048) |
0.3 | 1.7 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 2.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 3.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.3 | 1.0 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.3 | 1.0 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.3 | 1.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.3 | 1.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.3 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.0 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.3 | 3.7 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 3.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.3 | 2.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.3 | 3.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.3 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.3 | 3.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.3 | 1.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 1.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.7 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.3 | 0.3 | GO:0010157 | response to chlorate(GO:0010157) |
0.3 | 1.6 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.3 | 1.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 6.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 1.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 1.0 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.3 | 1.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.3 | 1.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 1.3 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.3 | 1.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.3 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 6.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 0.9 | GO:0042245 | RNA repair(GO:0042245) |
0.3 | 1.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 | 1.2 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 0.3 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.3 | 1.8 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.3 | 4.9 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 3.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 3.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.3 | 8.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 1.2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.3 | 3.3 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.3 | 0.9 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.3 | 0.3 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.3 | 0.9 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.3 | 3.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 7.2 | GO:0060004 | reflex(GO:0060004) |
0.3 | 1.2 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.3 | 1.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 2.3 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.3 | 3.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 0.8 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.3 | 4.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.1 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.3 | 0.6 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.3 | 4.7 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.3 | 0.3 | GO:0060022 | hard palate development(GO:0060022) |
0.3 | 1.6 | GO:0034332 | cell-substrate adherens junction assembly(GO:0007045) adherens junction organization(GO:0034332) focal adhesion assembly(GO:0048041) |
0.3 | 0.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.3 | 1.1 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.3 | 1.1 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.3 | 1.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 1.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 0.3 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 4.0 | GO:0016573 | histone acetylation(GO:0016573) |
0.3 | 0.8 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.3 | 1.3 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.3 | 1.6 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.3 | 2.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 1.6 | GO:0033619 | membrane protein ectodomain proteolysis(GO:0006509) membrane protein proteolysis(GO:0033619) |
0.3 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 3.7 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.3 | 3.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 0.3 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
0.3 | 13.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 2.6 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.3 | 1.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.3 | GO:1903793 | positive regulation of anion transport(GO:1903793) |
0.3 | 0.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 1.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.3 | 0.3 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 1.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 5.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 1.3 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.2 | 0.5 | GO:0001300 | chronological cell aging(GO:0001300) |
0.2 | 1.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 3.7 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.2 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.2 | 0.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 1.5 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 0.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 0.7 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
0.2 | 0.7 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.2 | 3.6 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.2 | 1.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 1.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 2.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.7 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 0.7 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 1.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.2 | 1.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.5 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.2 | 0.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 3.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
0.2 | 1.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.2 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.7 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.2 | 2.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 2.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.2 | 0.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.2 | 1.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 1.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.2 | 0.9 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.9 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.2 | 0.4 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.2 | 1.5 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.2 | 2.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.4 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 1.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 0.6 | GO:1990029 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
0.2 | 1.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.2 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 1.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.2 | 0.2 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.2 | 2.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.2 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) |
0.2 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 1.0 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 1.6 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 0.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.2 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.2 | 0.6 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.2 | 1.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 2.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.6 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 1.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.2 | 2.8 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.2 | 0.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.4 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 2.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.2 | 1.4 | GO:2000491 | regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.8 | GO:1905123 | regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
0.2 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.8 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.2 | 1.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.2 | 0.8 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.2 | 0.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 1.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 2.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 1.4 | GO:0097319 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.2 | 2.0 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 2.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.6 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.2 | 0.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) dense core granule exocytosis(GO:1990504) |
0.2 | 1.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 1.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 1.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.4 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 0.2 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.2 | 1.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 3.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 1.4 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.2 | 1.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 3.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.6 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.2 | 1.3 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 2.9 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.2 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.2 | 3.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 1.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 1.9 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 3.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.8 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 1.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.2 | 1.3 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.2 | 0.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 0.7 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.2 | 1.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.2 | 1.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 2.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 0.9 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.2 | 1.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.2 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 1.3 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.2 | 1.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.5 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 0.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 2.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.2 | 0.5 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.2 | 0.5 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.2 | 0.2 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 1.9 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 10.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.2 | 1.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 1.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.2 | 3.1 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 2.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 3.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.2 | 2.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 0.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 5.2 | GO:0050821 | protein stabilization(GO:0050821) |
0.2 | 1.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.2 | 1.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 0.5 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 1.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.2 | 0.7 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.2 | 0.5 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.2 | 0.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 3.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 2.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.2 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 1.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 1.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 1.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.2 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.2 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
0.2 | 4.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 1.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 0.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.2 | 10.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 1.4 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.2 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 1.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 0.2 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.2 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 0.9 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 0.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 2.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 2.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 2.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.6 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.9 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 1.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.1 | 0.4 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 2.6 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 3.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.6 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 1.6 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.7 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 0.1 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.1 | 0.1 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.1 | 2.6 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.9 | GO:0061053 | somite development(GO:0061053) |
0.1 | 0.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 1.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.8 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 1.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.6 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 3.2 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.1 | 0.6 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 1.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 2.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 1.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.4 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.3 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
0.1 | 0.7 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.3 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
0.1 | 0.3 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 1.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 3.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 1.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 1.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.9 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.4 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.5 | GO:0045137 | gonad development(GO:0008406) development of primary sexual characteristics(GO:0045137) |
0.1 | 0.4 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.1 | 3.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 7.0 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 1.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 2.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.4 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.1 | 0.2 | GO:0051794 | catagen(GO:0042637) regulation of catagen(GO:0051794) |
0.1 | 0.7 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 1.7 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:0042495 | toll-like receptor 1 signaling pathway(GO:0034130) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.6 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
0.1 | 3.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.6 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 2.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 7.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.7 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 | 1.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 2.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.1 | 1.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 0.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 3.4 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.4 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.1 | 0.7 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 | 0.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.4 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 1.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.5 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.1 | GO:0050720 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
0.1 | 12.9 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.7 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 1.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 1.0 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.1 | 0.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.1 | 2.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.7 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.7 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 0.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 3.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.7 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.1 | 4.1 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.1 | 2.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.7 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.9 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 1.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 2.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 2.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 1.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 1.5 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 1.0 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 1.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 1.4 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.7 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 4.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 1.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.2 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.1 | 0.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.3 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.1 | 2.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.8 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.7 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.2 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.8 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.4 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 1.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 1.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.1 | GO:0048839 | inner ear development(GO:0048839) |
0.1 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
0.1 | 0.3 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.1 | 0.4 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.1 | 1.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.1 | 0.7 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 1.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.5 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
0.1 | 0.8 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 2.0 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 1.8 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.3 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 1.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.1 | 1.9 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.5 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 1.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 5.0 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.5 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.1 | 2.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.2 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.7 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.1 | 1.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 2.3 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 1.0 | GO:1904646 | cellular response to beta-amyloid(GO:1904646) |
0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.1 | 0.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.3 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 1.4 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 1.5 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.1 | 0.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.3 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 1.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.3 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 1.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:1901739 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) regulation of myoblast fusion(GO:1901739) |
0.1 | 3.5 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.3 | GO:0061196 | fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
0.1 | 0.3 | GO:0070781 | response to biotin(GO:0070781) |
0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 2.8 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.3 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.1 | 1.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 3.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 1.7 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 2.2 | GO:0098743 | cell aggregation(GO:0098743) |
0.1 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.2 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.1 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.3 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.5 | GO:1901355 | cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
0.1 | 1.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 1.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 1.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 1.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.5 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 1.5 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.2 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 1.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.0 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 2.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 7.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.1 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.1 | 0.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.9 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.4 | GO:0045453 | bone resorption(GO:0045453) |
0.1 | 1.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.6 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.1 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 4.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 1.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.6 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.7 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.3 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.1 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.1 | 0.7 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 4.4 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.4 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.1 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0016447 | somatic recombination of immunoglobulin gene segments(GO:0016447) |
0.1 | 4.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.1 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 1.6 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.3 | GO:0071478 | cellular response to radiation(GO:0071478) |
0.1 | 1.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.2 | GO:0051801 | cytolysis by symbiont of host cells(GO:0001897) cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
0.1 | 2.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 8.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 1.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 0.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0002888 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.9 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.2 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.1 | 0.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 8.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.9 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:2000973 | positive regulation of B cell apoptotic process(GO:0002904) regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.1 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
0.1 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0060491 | regulation of cell projection assembly(GO:0060491) |
0.1 | 0.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 1.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.6 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:1990036 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.4 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.8 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 | 0.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.1 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
0.1 | 0.2 | GO:0048511 | rhythmic process(GO:0048511) |
0.1 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.1 | 0.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.1 | 0.4 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.6 | GO:0098877 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.1 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 1.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 1.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.1 | 3.4 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 1.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 1.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.4 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 4.3 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.1 | 0.6 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 1.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 1.7 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.2 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.6 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.1 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.9 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.1 | 1.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 1.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 1.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 1.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 2.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.1 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.5 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.3 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 1.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.1 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.3 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 2.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.0 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.7 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 1.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.0 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 2.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.0 | 2.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.0 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 2.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.6 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.3 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.0 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.5 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.0 | 0.5 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.1 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.0 | 1.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.9 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.3 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.0 | 0.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.3 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.0 | 0.0 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 0.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.0 | 0.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.0 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.0 | 0.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.0 | 3.0 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.1 | GO:0044819 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.6 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.0 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.2 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.9 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.4 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 1.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.9 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.2 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.0 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 4.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 1.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.5 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.2 | GO:0038111 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.2 | GO:0015908 | fatty acid transport(GO:0015908) |
0.0 | 0.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.0 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.3 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.3 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.0 | 1.6 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
0.0 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 1.1 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0008291 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.0 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.4 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.3 | GO:2000347 | negative regulation of myoblast fusion(GO:1901740) positive regulation of hepatocyte proliferation(GO:2000347) |
0.0 | 3.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.6 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.0 | 0.2 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.1 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.0 | 0.1 | GO:0002190 | cap-independent translational initiation(GO:0002190) |
0.0 | 5.7 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.0 | 0.2 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.0 | 0.1 | GO:0010517 | regulation of phospholipase activity(GO:0010517) |
0.0 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.2 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.1 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.2 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.0 | 0.2 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.1 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.0 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.0 | GO:0072611 | interleukin-13 secretion(GO:0072611) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.0 | 0.6 | GO:0050871 | positive regulation of B cell activation(GO:0050871) |
0.0 | 0.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 2.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 1.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.0 | GO:0071674 | positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.0 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.0 | 0.2 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.7 | GO:0048208 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 0.0 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.0 | 0.7 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.0 | 0.1 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.0 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0019046 | release from viral latency(GO:0019046) |
0.0 | 0.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 15.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.9 | 20.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.4 | 11.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.4 | 4.1 | GO:0001534 | radial spoke(GO:0001534) |
1.0 | 11.4 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.9 | 13.6 | GO:0043219 | lateral loop(GO:0043219) |
0.8 | 4.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.8 | 5.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.7 | 2.9 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.7 | 10.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 2.1 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.7 | 7.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 15.0 | GO:0043203 | axon hillock(GO:0043203) |
0.6 | 44.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 3.7 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.6 | 2.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.6 | 1.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 2.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.6 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.5 | 1.6 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.5 | 2.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.5 | 1.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.5 | 2.1 | GO:1990742 | microvesicle(GO:1990742) |
0.5 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 2.0 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.5 | 1.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.5 | 12.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 1.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 1.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.5 | 1.4 | GO:0097444 | spine apparatus(GO:0097444) |
0.5 | 2.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.4 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 7.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 2.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.4 | 2.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 2.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 4.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 1.5 | GO:0031213 | RSF complex(GO:0031213) |
0.4 | 3.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 1.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.4 | 2.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.4 | 2.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.4 | 0.4 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.4 | 0.7 | GO:0070187 | telosome(GO:0070187) |
0.3 | 1.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 1.7 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.3 | 2.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 2.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 13.5 | GO:0098553 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.3 | 3.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 4.9 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 0.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 2.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 4.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 5.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.4 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.3 | 2.3 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 2.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 1.1 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 1.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.3 | 0.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 0.8 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.3 | 3.7 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.3 | 1.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 2.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 1.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 1.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.3 | 2.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.2 | 1.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 1.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 5.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 4.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.7 | GO:0018444 | translation release factor complex(GO:0018444) |
0.2 | 1.4 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 3.1 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 7.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 7.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 3.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 1.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.2 | 1.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.2 | 6.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 4.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 4.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 6.3 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.2 | 4.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 3.9 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 1.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.2 | 4.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 30.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 8.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 3.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 5.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 15.9 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.6 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.2 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 4.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 14.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 2.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 2.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.9 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 2.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.4 | GO:0002177 | manchette(GO:0002177) |
0.2 | 3.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.9 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 3.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.0 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 3.1 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 1.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.2 | 1.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 3.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.5 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.2 | 1.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 3.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 5.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.8 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 2.2 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 1.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 15.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.6 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 2.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 3.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 2.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 11.0 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.3 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 0.1 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 8.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.1 | 8.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.5 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.1 | 0.4 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 3.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 1.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 1.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 3.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of early endosome membrane(GO:0098559) |
0.1 | 1.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 3.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 7.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 9.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 1.5 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 8.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 2.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.3 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.1 | 0.2 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.2 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 12.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.8 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.2 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 2.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 2.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 4.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 14.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 3.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 9.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 2.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 6.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 3.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 2.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.2 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.1 | 1.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 7.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 1.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.4 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 2.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 1.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.6 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 2.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.3 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 7.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 13.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 6.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.3 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 4.2 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 3.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 2.2 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 1.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 17.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 4.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.0 | 0.1 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 1.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 1.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.0 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 2.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.0 | 0.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 2.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 11.5 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 4.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.8 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 5.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 2.7 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.1 | GO:0048500 | signal recognition particle(GO:0048500) |
0.0 | 3.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.5 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.7 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 2.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 2.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.1 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.0 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.9 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 3.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) male pronucleus(GO:0001940) |
0.0 | 0.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.0 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.7 | 5.0 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
1.4 | 20.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.3 | 3.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.3 | 3.9 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
1.3 | 3.9 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
1.2 | 5.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.2 | 4.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.2 | 6.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.1 | 4.3 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.0 | 12.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
1.0 | 4.0 | GO:1990175 | EH domain binding(GO:1990175) |
1.0 | 5.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.0 | 12.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.9 | 4.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.9 | 10.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.9 | 3.4 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.8 | 4.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.8 | 9.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.8 | 4.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.7 | 6.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 5.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.7 | 0.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.7 | 2.0 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.6 | 0.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.6 | 1.9 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.6 | 1.9 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.6 | 11.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 1.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.6 | 2.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.6 | 13.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.6 | 3.0 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.6 | 1.8 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.6 | 2.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.6 | 6.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 4.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.6 | 5.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 4.0 | GO:0045118 | azole transporter activity(GO:0045118) |
0.6 | 1.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.6 | 9.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.5 | 2.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.5 | 3.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 5.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 2.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 2.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 2.0 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.5 | 7.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 5.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 2.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.5 | 5.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.5 | 6.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 1.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 1.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.5 | 3.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 2.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.4 | 1.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.4 | 2.6 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 3.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 2.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.4 | 2.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.4 | 1.3 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.4 | 1.2 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.4 | 1.6 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.4 | 2.0 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.4 | 2.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 1.6 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.4 | 6.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 3.5 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.4 | 1.5 | GO:0004641 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.4 | 16.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.4 | 1.5 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.4 | 1.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 3.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.4 | 1.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 1.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.4 | 1.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 2.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 1.4 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 3.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 0.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.4 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.7 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 2.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 11.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 0.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 2.1 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 1.0 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.3 | 1.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.3 | 1.0 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.3 | 2.7 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.3 | 2.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 7.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 1.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 1.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 1.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 1.6 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 1.6 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.3 | 4.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 4.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 0.9 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.3 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 1.2 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.3 | 1.5 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.3 | 0.9 | GO:0032093 | SAM domain binding(GO:0032093) |
0.3 | 1.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.3 | 0.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) tubulin-glutamic acid ligase activity(GO:0070740) |
0.3 | 0.9 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 2.0 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.3 | 2.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 0.6 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.3 | 6.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 2.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
0.3 | 1.7 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.3 | 3.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 5.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 10.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 1.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.3 | 2.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 10.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 3.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 3.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 1.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.3 | 1.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.2 | 1.0 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 1.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 5.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 2.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 0.7 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.2 | 3.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.2 | 3.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 1.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 2.1 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 2.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 4.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 3.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 0.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 2.9 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.2 | 0.7 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.2 | 0.7 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.2 | 3.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.6 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 8.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 5.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 1.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 0.6 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.2 | 0.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 0.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 0.8 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.2 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 8.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 60.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 1.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.2 | 2.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.2 | 3.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 1.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.2 | 6.7 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.6 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.2 | 0.8 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 1.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 1.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 2.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 8.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.6 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.2 | 0.6 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 1.3 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 1.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 3.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 0.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 6.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 2.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 4.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 2.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.6 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.2 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 2.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 2.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.5 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.2 | 2.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 2.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 2.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 1.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 1.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 10.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 2.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.5 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.2 | 0.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.2 | 4.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.6 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 0.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 7.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 6.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 1.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 0.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 2.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.4 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.1 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 1.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.1 | 7.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 3.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 1.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 1.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 1.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 1.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 3.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.5 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 1.9 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0017076 | purine nucleotide binding(GO:0017076) |
0.1 | 4.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 3.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 4.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.1 | 1.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 6.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 2.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 3.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 5.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 2.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 1.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 6.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 4.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 0.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 3.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 8.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 2.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 5.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 2.9 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.9 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 0.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.3 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 15.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 3.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 4.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 1.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 0.3 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.1 | 0.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 2.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.4 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 2.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.3 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.1 | 0.6 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.1 | 4.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 7.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.1 | 0.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 7.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 1.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.5 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.1 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 2.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 8.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.6 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.4 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 2.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 2.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.3 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.1 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.6 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 4.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 2.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 4.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.1 | 1.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 4.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.9 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 19.8 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 1.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 2.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 2.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 3.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.2 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 5.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.2 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.3 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 6.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.1 | 0.3 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 3.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 0.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 2.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 1.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 2.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
0.1 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 1.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 3.0 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 8.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 12.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.8 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 26.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.6 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 8.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 1.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.1 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 1.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 1.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.2 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.0 | 0.1 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.0 | 1.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 1.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.0 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 1.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 3.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.0 | 2.5 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 1.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 1.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 2.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 1.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.2 | GO:0052845 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.0 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 1.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 0.5 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 4.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 1.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 0.2 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 4.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0032427 | GBD domain binding(GO:0032427) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.0 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.2 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0016769 | transaminase activity(GO:0008483) transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.2 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.0 | 2.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.1 | GO:0000828 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 3.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 14.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 2.4 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 4.4 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.0 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.0 | 0.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 25.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 14.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 23.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 3.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 25.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 11.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 5.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 8.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 14.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 11.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 9.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 1.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 12.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 4.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 2.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 9.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 17.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 13.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 5.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 5.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 5.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 9.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 14.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 7.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 8.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 4.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 7.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 5.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 2.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 12.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 3.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 4.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 8.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 25.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 3.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 6.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 3.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 3.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 3.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 5.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 2.0 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 2.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 2.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 11.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 7.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 13.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 11.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 12.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 24.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 13.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 6.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 17.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 32.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 8.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 9.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 9.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 6.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 5.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 7.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 7.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 10.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 5.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 4.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 1.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 4.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 3.6 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 0.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 4.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 4.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 18.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 3.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 6.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 8.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 3.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 3.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 6.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 2.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 5.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 12.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.5 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 3.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 6.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 3.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 3.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 3.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 5.0 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.1 | 2.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.1 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 4.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 5.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 2.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 2.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 4.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 3.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 4.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 3.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 3.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 5.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 2.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 2.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 19.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 2.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 2.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 1.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |